Objective: This study aims to investigate the possible role of vitamin D deficiency in primary dysmenorrhea by assessing serum 25-hydroxyvitamin D 3 levels in a cohort which includes young Turkish women with primary dysmenorrhea and healthy controls. Materials and methods: A total of 683 women who were aged between 18 and 25 years and who were consecutively admitted to the study center were eligible. After the exclusion of 55 women, 184 women with primary dysmenorrhea were randomly assigned into the dysmenorrhea group and 184 women without dysmenorrhea were randomly allocated into the control group. Results: The dysmenorrhea group had significantly less consumption of dairy products (p ¼ 0.001), lower serum calcium (p ¼ 0.001), lower serum vitamin D (p ¼ 0.001) and higher serum parathyroid hormone (p ¼ 0.001) than those of the control group. Hyperparathyroidism was significantly less frequent whereas vitamin D deficiency was significantly more frequent in the dysmenorrhea group (p ¼ 0.001 for each). The dysmenorrhea patients with vitamin D deficiency had significantly higher visual analogue scale (VAS) scores (p ¼ 0.001). Depression, irritability, mood swings, fatigue, headache and breast tenderness were significantly more frequent in the vitamin D deficiency group (p < 0.05 for all). The VAS scores of the dysmenorrhea patients correlated positively and significantly with serum parathyroid hormone levels (r ¼ 0.666, p ¼ 0.001) whereas these VAS scores correlated negatively and significantly with serum vitamin D levels (r ¼ À0.713, p ¼ 0.001). Discussion: The significant and positive correlation between vitamin D levels and VAS scores and the significant reduction in serum vitamin D levels of the dysmenorrhea patients designate the possible role of vitamin D deficiency in the primary dysmenorrhea.
Introduction
Primary dysmenorrhea is characterized by uterine cramping which causes suprapubic pain that occurs just before or during menstruation in the absence of any pelvic pathologic conditions. Primary dysmenorrhea is observed in at least half of the menstruating women, often resulting in the interruption of school and work schedules and ultimately leading to educational and economical considerations. Although the pathogenesis of primary dysmenorrhea has not been clarified, it has been proposed that an excessive release of prostaglandins triggers uterine contractions and lower abdominal pain [1, 2] .
Previously published studies have identified younger age, younger age at menarche, nulliparity, higher and longer menstrual flow, smoking and positive family history as the associated risk factors. These studies have also indicated the possible role of certain nutrients and dietary habits in the etiopathogenesis of dysmenorrhea. For instance, dysmenorrhea is related with irregular eating, obesity and history of an attempt to lose weight. Moreover, it has been found that the intake of caffeine and sugar is increased and the consumption of vegetables and fruits is reduced in dysmenorrhea patients (Table 1) [3e17]. Recently, two Jordanian studies have reported about the relationship between low calcium intake or vitamin D insufficiency and dysmenorrhea in adolescents and young women with dysmenorrhea [18, 19] . Such a relationship has been attributed to the physiological effects of calcium on muscle contractility and relaxation [20, 21] . Since calcium homeostasis is maintained by the conjoint actions of calcitonin, parathyroid hormone and 25-hydroxyvitamin D 3 , it can be expected that these three hormones would also participate in the pathophysiology of primary dysmenorrhea [22, 23] .
The present study aims to investigate the possible role of vitamin D 3 deficiency in primary dysmenorrhea by assessing serum 25-hydroxyvitamin D 3 levels in a cohort which includes young Turkish women with primary dysmenorrhea and healthy controls.
Material and methods
This prospective, randomized, case-controlled study was approved by the Institutional Review Board and Ethical Committee of Afyon Kocatepe University where it was undertaken from January 2015 to January 2016. Written informed consent was obtained from all participants included in the study.
Study design and patients
A total of 423 women who were aged between 18 and 25 years and who were consecutively admitted to the department of gynecology at the study center were eligible for the study. Twentytwo women who had pelvic pathologies, twelve women who had systemic diseases, ten women who had acute infections, six women who regularly used calcium or vitamin D supplements and five women who refused to participate were excluded. A total of 184 women who had regular menstrual cycles (occurring in 21e35 days, with menstruation lasting 3e7 days) and who experienced at least 4 consecutive painful periods in the past 6 months with the pain starting one day before or on the day of onset of bleeding were randomly assigned into the dysmenorrhea group. Another total of 184 women without dysmenorrhea were randomly allocated into the control group. Randomization was performed by sequentially numbered, sealed, opaque envelopes (Refer Fig. 1 ). The participants also answered questions regarding their consumption of dairy products. The intake of dairy products was determined on daily basis as less than 1, 1 to 2 and more than 2 servings per day. A dairy serving was defined as: 1 cup of milk or yogurt, 2 tablespoons of butter, or 2 tablespoons (or ¼ cup) of cheese.
Moreover, the participants were requested to answer questions about their recurrent experience of 12 physical and psychological symptoms emerging during the premenstrual period. Psychological symptoms of depression, irritability, mood swings, social withdrawal, change in appetite and cravings for sweet or salty foods are recorded, along with physical symptoms such as general fatigue, headaches, nausea, abdominal bloating, and breast tenderness. The severity of dysmenorrhea pain was assessed by using visual analogue scale (VAS) scoring system which is based on numerical rating between 1 and 10.
Laboratory studies
Venous blood samples of 10 ml were collected into heparinized tubes. Serum concentrations of 25-hydroxyvitamin D 3 and parathyroid hormone were measured by a chemiluminescent assay (Elecsys 2010 analyzer, Roche Diagnostics, Mannheim, Germany). The intra-assay and inter-assay coefficients of variation (CVs) for vitamin D were 1.3% and 1.8% respectively while the intra-assay and inter-assay CVs for parathormone were 1.7% and 1.5% respectively. Serum 25-hydroxyvitamin D 3 levels <12 ng/ml indicated vitamin D deficiency and serum parathyroid hormone concentrations >54 pg/ ml referred to hyperparathyroidism.
Statistical analysis
Collected data were analyzed by Statistical Package for Social Sciences version 18.0 (SPSS-IBM Inc., Armonk, NY, USA). Continuous variables were expressed as mean ± standard deviation (range: minimumemaximum) whereas categorical variables were denoted as numbers or percentages. Student t-test, chi-square test and Mann Whitney U-test were used for the comparisons. Spearman correlation test was used to detect the correlations among the variables. Two-tailed p values less than 0.05 were accepted to be statistically significant. A post hoc analysis was carried out to make a retrospective power analysis and it was determined that a cohort size of 368 women (184 healthy controls and 184 patients with primary dysmenorrhea) had 84.6% power to detect a difference at the 0.05 significance level. Table 2 compares the demographic, clinical and biochemical characteristics of the dysmenorrhea and control groups. When compared with the healthy controls, the dysmenorrhea patients had significantly more menstrual bleeding (p ¼ 0.004), less consumption of dairy products (p ¼ 0.001), lower calcium (p ¼ 0.001), lower serum 25-hydroxyvitamin D 3 (p ¼ 0.001), higher serum parathyroid hormone (p ¼ 0.001) and higher VAS scores (p ¼ 0.001). Positive family history, vitamin D deficiency and hyperparathyroidism were significantly more frequent in the dysmenorrhea group (p ¼ 0.001 for each). Table 3 demonstrates that depression, irritability, mood swings, fatigue, headache, breast Table 4 shows that dysmenorrhea patients with 25-hydroxyvitamin D 3 deficiency had significantly shorter height, longer menstrual cycle, longer menstrual bleeding, less menstrual bleeding, less consumption of dairy products and higher VAS scores (respectively p ¼ 0.014, p ¼ 0.002, p ¼ 0.001, p ¼ 0.001, p ¼ 0.001 and p ¼ 0.001). The rates of low education and unemployment were also significantly more frequent in this group (p ¼ 0.001 for both).
Results
Depression, irritability, mood swings, fatigue, headache and breast tenderness were significantly more frequent in the 25-hydroxyvitamin D 3 deficiency group (p < 0.05 for all). However, nausea, social withdrawal, change in appetite and food craving were significantly less frequent in the 25-hydroxyvitamin D 3 deficiency group (p ¼ 0.001 for each) ( Table 5 Risk factors that are associated with dysmenorrhea include younger age, younger age at menarche, nulliparity, higher and longer menstrual flow, smoking and positive family history. The findings of the present study also designate higher menstrual flow and positive family history as the underlying risk factors for dysmenorrhea [3e17]. The possible relationship between dietary habits and dysmenorrhea as well as the widespread location of vitamin D receptors throughout the human body and and the expression of 1a-hydroxylase in decidual cells imply that vitamin D may participate in the pathogenesis of dysmenorrhea [27, 28] .
This study indicates the overall prevalence of vitamin D deficiency (<12 ng/ml) as 44.5% in a cohort of 398 young Turkish women. This number is compatible with those previously published in literature. The prevalence of vitamin D deficiency was found to be 50.4% in a cohort of 258 healthy Turkish women [29] . Later, Ergur et al. detected moderate vitamin D deficiency in 54.3% of women with singleton term pregnancies and 45.2%of nonpregnant fertile women [30] . In a similar study, the prevalence of severe vitamin D deficiency was 45.9% in a cohort of 229 women with singleton first-trimester pregnancies [31] . The prevalence of vitamin D deficiency and hyperparathyroidism is 84.2% and 43.5% respectively in this cohort of 184 Turkish women with dysmenorrhea. In a study by Abdul-Razzak et al., the prevalence of vitamin D deficiency (<10 ng/ml), vitamin D insufficiency and hyperparathyroidism was 9%, 80% and 48% respectively among 56 young Jordanian women with severe dysmenorrhea [19] . However, vitamin D insufficiency and hyperparathyroidism were observed in respectively 56.5% and 27.6% of young Jordanian women with dysmenorrhea [32] . These contradictory results may be due to the differences in the cut-off values and the timing of blood sampling for parathyroid hormone measurements.
This study indicates that 75.5% of the dysmenorrhea patients consumed <1 serving of dairy products per day and only 6% of these patients consumed >2 servings of dairy products per day. In a study, only 36% of the students who consumed 3 or 4 servings of dairy products per day had severe dysmenorrhea whereas 97% of the students who did not ingest any dairy products complained of severe dysmenorrhea [19] . In a smaller cohort, nearly 50% of the young women with dysmenorrhea had <1 serving of dairy products per day [18] . Vitamin D insufficiency or deficiency has been linked to low socioeconomic status in prior studies [33e35] . Similarly, dysmenorrhea patients with vitamin D deficiency have a low education rate of 53.5% and an unemployment rate of 93% in this study.
The present study points out depression (50.5%), irritability (48.9%), mood swings (46.7%), fatigue (46.7%) and headache (44.6%) as the most frequent premenstrual symptoms. In a Jordanian study, the most commonly encountered premenstrual symptoms were fatigue (72.9%), mood swings (72.3%), anxiety (68.9%), abdominal bloating (68.9%) and depression (58.8%) [32] . Calcium has been addressed as a micronutrient which is directly associated with the severity of premenstrual symptoms. As vitamin D and parathyroid hormone regulate calcium homeostasis, it can be hypothesized that they may also have a role in promoting premenstrual symptoms [36, 37] . Accordingly, Bertone-Johnson et al. has related low dietary intake of vitamin D with the emergence of premenstrual symptoms [38] . In addition, it has been demonstrated that high calcium intake or vitamin D supplementation contributes to the alleviation of premenstrual symptoms [39e43]. However, Obeidat et al. were unable to show a significant difference between vitamin D levels of women with and without premenstrual symptoms. They also failed to detect any significant relationship between high dietary calcium intake and premenstrual symptoms except headache and social withdrawal [32] .
As for the present study, depression, irritability, mood swings, fatigue, headache and breast tenderness are significantly more frequent while nausea, social withdrawal, change in appetite and food craving are significantly less frequent in the vitamin D deficiency group. Such discrepancies may be attributed to the differences in demographic and clinical characteristics of the reviewed participants and seasonal variations in serum concentrations of vitamin D. The possible correlation between vitamin D deficiency and premenstrual symptoms suggest that vitamin D participates in the etiopathogenesis of these symptoms and vitamin D can be used to treat these symptoms. As known, nearly every tissue and cell type in the body (especially myocardial cells, neurons and adipocytes) has receptors for vitamin D meaning that they all require vitamin D for adequate functioning. Additionally, vitamin D regulates genes that control cell growth and development, immune function, and metabolic control. Any interference with vitamin D metabolism may lead to the psychological, neurological and gastrointestinal symptoms that accompany dysmenorrhea [23e26] .
To the best of our knowledge, this is the first randomized controlled study which aims to assess serum vitamin D levels of 
